Search Within

Kenneth Ho-Ming Yu

Formats
  1. Meeting Abstract (81)
  2. Journal Article (78)
  3. Review (2)
  4. Book Section (1)
  5. Conference Paper (1)
Groups
  1. Center for Pancreatic Cancer Research (163)
  2. Department of Medicine (163)
  3. Gastrointestinal Oncology Service (163)
  4. Solid Tumor Oncology Division (163)
  5. Epidemiology and Biostatistics (57)
  6. GSK Faculty (57)

More Groups

People
  1. Eileen O'Reilly (120)
  2. Maeve Lowery (52)
  3. Anna Varghese (50)
  4. David Kelsen (44)
  5. Marinela Capanu (44)
  6. Wungki Park (33)

More People

Years
  1. 2025 (1)
  2. 2024 (10)
  3. 2023 (10)
  4. 2022 (11)
  5. 2021 (14)
  6. 2020 (18)

More Years

Publications
  1. Journal of Clinical Oncology (67)
  2. Clinical Cancer Research (9)
  3. Cancer (8)
  4. Cancers (6)
  5. Annals of Oncology (4)
  6. Cancer Medicine (4)

More Publications

Publishers
  1. American Society of Clinical Oncology (68)
  2. American Association for Cancer Research (15)
  3. Wiley Blackwell (14)
  4. Elsevier Inc. (10)
  5. Oxford University Press (10)
  6. MDPI (7)

More Publishers

Results (163)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Salvage ablative radiotherapy for isolated local recurrence of pancreatic adenocarcinoma following definitive surgery
    Journal Article

    Dee, E. C.; Ng, V. C.; O’Reilly, E. M.; Wei, A. C.; Lobaugh, S. M.; Varghese, A. M.; Zinovoy, M.; Romesser, P. B.; Wu, A. J.; Hajj, C.; more...
    Journal of Clinical Medicine (2024)

    Fulltext@MSK | Save
  • Favorable survival after definitive ablative RT in surgically resectable pancreatic cancer patients
    Meeting Abstract

    Reyngold, M.; O'Reilly, E.; Zinovoy, M.; Hajj, C.; Wu, A. J.; Cuaron, J.; Romesser, P.; Varghese, A. M.; Park, W.; Yu, K.; more...
    International Journal of Radiation Oncology, Biology, Physics (2023)

    Fulltext@MSK | Save
  • Dopaminergic Neuronal Cell Therapy for Parkinson's Disease: Results from a Phase 1 Study of Bemdaneprocel
    Meeting Abstract

    Henchcliffe, C.; Sarva, H.; Lozano, A.; Fasano, A.; Kalia, S.; Brennan, C.; Yu, K.; Yountz, M.; Enayetallah, A.; Yountz, M.; more...
    Annals of Neurology (2023)

    Fulltext@MSK | Save
  • Clinical utility of next generation sequencing (NGS) on circulating tumor DNA (ctDNA) in patients (pts) with pancreatic cancer (PC)
    Meeting Abstract

    Keane, F.; Saadat, L.; O'Connor, C.; Chou, J. F.; Brannon, A. R.; Cowzer, D.; Crowley, F.; Debnath, N.; Bowman, A.; Xu, F.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • A phase I/II study of durvalumab and stereotactic ablative body radiotherapy (SABR) in locally advanced (LA) and borderline resectable (BR) pancreatic cancer
    Meeting Abstract

    Tuli, R.; Keane, F.; Schoenfeld, J. D.; O'Connor, C.; White, C.; Chou, J. F.; Schwartz, C.; Larsen, M.; Brenner, R.; Park, W.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Phase 2 trial of pembrolizumab and olaparib (POLAR) maintenance for patients (pts) with metastatic pancreatic cancer (mPDAC): Two cohorts B non-core homologous recombination deficiency (HRD) and C exceptional response to platinum-therapy
    Meeting Abstract

    Park, W.; O'Connor, C.; Chou, J. F.; Schwartz, C.; Varghese, A. M.; Larsen, M.; Balogun, F.; Brenner, R.; Yu, K. H.; Diguglielmo, E.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Prior irinotecan exposure does not preclude benefit to liposomal irinotecan in patients with metastatic pancreatic ductal adenocarcinoma
    Journal Article

    Yu, K. H.; Cockrum, P.; Surinach, A.; Lamarre, N.; Wang, S.; O'Reilly, E. M.
    Cancer Medicine (2023)

    Fulltext@MSK | Save
  • The SHARON trial: A study of melphalan, BCNU, hydroxocobalamin, ascorbic acid, and autologous stem cell rescue for metastatic pancreatic cancer with an inherited BRCA mutation
    Meeting Abstract

    Yu, K. H.; Weekes, C. D.; Chen, Y. B. A.; Glazier, J. A.; Glazier, A.; Dahi, P.; Giralt, S.; O'Reilly, E. M.
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • A phase II study of durvalumab and stereotactic ablative body radiotherapy (SABR) in locally advanced pancreatic adenocarcinoma (LA PDAC)
    Meeting Abstract

    Keane, F.; Schoenfeld, J. D.; Crowley, F.; O'Connor, C. A.; White, C.; Schwartz, C.; Brenner, R.; Larsen, M.; Park, W.; Varghese, A. M.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Adjuvant modified FOLFIRINOX (mFFX) for resected pancreatic cancer (PDAC): Real world outcomes (RWO)
    Meeting Abstract

    Keane, F.; Balogun, F.; O'Connor, C.; Crowley, F.; Chan, A.; Cowzer, D.; Chou, J. F.; Park, W.; Varghese, A. M.; Yu, K. H.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save